Bone health in survivors of childhood cancer

The Lancet Diabetes and Endocrinology

Volumn 3, Issue 7, 2015, Pages 496-497

  Neville, Kristen A ^a,b   Cohn, Richard J ^a,b  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; GLUCOCORTICOID; METHOTREXATE; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; BONE DENSITY; BONE DEVELOPMENT; BONE DISEASE; BONE MASS; BONE NECROSIS; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; DISEASE PREDISPOSITION; FOLLOW UP; FRACTURE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK POPULATION; HORMONE DEFICIENCY; HUMAN; LYMPHOMA; MEDICAL RESEARCH; NOTE; NUTRITIONAL STATUS; OPTIMAL DRUG DOSE; OSTEOCHONDROMA; OSTEOPENIA; PATIENT MONITORING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RADIATION DOSE; RISK ASSESSMENT; SKULL IRRADIATION; TREATMENT INDICATION; WHOLE BODY RADIATION; ADVERSE EFFECTS; CHEMORADIOTHERAPY; DRUG EFFECTS; NEOPLASMS; RADIATION RESPONSE; RISK FACTOR; SURVIVOR;

ANTINEOPLASTIC AGENTS; BONE DEVELOPMENT; CHEMORADIOTHERAPY; HUMANS; NEOPLASMS; RISK FACTORS; SURVIVORS;

EID: 84934436202     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(15)00029-7     Document Type: Note

References (12)

1. Ma NS, Gordon CM Pediatric osteoporosis: where are we now?. J Pediatr 2012, 161:983-990.
2. Wasilewski-Masker K, Kaste SC, Hudson MM, Esiashvili N, Mattano LA, Meacham LR Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature. Pediatrics 2008, 121:e705-e713.
3. Chemaitilly W, Sklar CA Endocrine complications in long-term survivors of childhood cancers. Endocr Relat Cancer 2010, 17:R141-R159.
4. van der Sluis IM, van den Heuvel-Eibrink MM Osteoporosis in children with cancer. Pediatr Blood Cancer 2008, 50(suppl):474-478.
5. Alos N, Grant RM, Ramsay T, et al. High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy. J Clin Oncol 2012, 30:2760-2767.
6. Polgreen LE, Petryk A, Dietz AC, et al. Modifiable risk factors associated with bone deficits in childhood cancer survivors. BMC Pediatr 2012, 12:40.
7. Neville KA, Walker JL, Cohn RJ, Cowell CT, White CP The prevalence of vitamin D deficiency is higher in adult survivors of childhood cancer. Clin Endocrinol (Oxf) 2015, published online Jan 19. 10.1111/cen.12721.
8. Wilson CL, Dilley K, Ness KK, et al. Fractures among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer 2012, 118:5920-5928.
9. Padhye B, Dalla-Pozza L, Little DG, Munns CF Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: a retrospective analysis. Pediatr Blood Cancer 2013, 60:1539-1545.
10. Isfan F, Kanold J, Merlin E, et al. Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-Up Study (LEA). Bone Marrow Transplant 2012, 47:684-693.
11. Vedi A, Neville K, Johnston K, Saravanja D, Cohn RJ Slipped capital femoral epiphyses after total body irradiation. Pediatr Blood Cancer 2014, 61:1140.
12. Taitz J, Cohn RJ, White L, Russell SJ, Vowels MR Osteochondroma after total body irradiation: an age-related complication. Pediatr Blood Cancer 2004, 42:225-229.